NCCN Guidelines Insights: Chronic Myeloid Leukemia, Version 1.2017.

Area of Science:

• Hematology
• Oncology
• Clinical Guidelines

Background:

• Chronic Myeloid Leukemia (CML) is a myeloproliferative neoplasm typically diagnosed in older adults, with a median age of onset at 67.
• While CML is rare in children, it can affect all age groups, necessitating tailored management strategies.
• Current NCCN guidelines address adult CML management but lack specific evidence-based recommendations for pediatric populations and pregnancy.

Purpose of the Study:

• To provide special considerations for managing Chronic Myeloid Leukemia (CML) during pregnancy.
• To address the lack of evidence-based recommendations for managing CML in pediatric patients.
• To supplement existing NCCN guidelines with insights relevant to reproductive-aged and pediatric CML patients.

Main Methods:

• Review of existing NCCN Guidelines for Chronic Myeloid Leukemia (CML).
• Identification of special considerations for CML management in specific populations (pregnancy, pediatrics).
• Discussion of clinical care team preparedness for fertility and pregnancy issues in reproductive-aged patients.

Main Results:

• The NCCN Guidelines provide recommendations for adult CML management (chronic and advanced phases).
• Special considerations are highlighted for managing CML during pregnancy.
• Management of CML in the pediatric population requires further evidence-based recommendations.

Conclusions:

• Clinical care teams must be prepared to discuss fertility and pregnancy with reproductive-aged CML patients.
• There is a need for evidence-based recommendations for pediatric CML management.
• These insights aim to guide clinicians in managing CML in these specific patient groups.